Cargando…
Altered glutamate–glutamine and amide proton transfer-weighted values in the hippocampus of patients with amnestic mild cognitive impairment: A novel combined imaging diagnostic marker
BACKGROUND AND PURPOSE: Early diagnosis of amnestic mild cognitive impairment (aMCI) and timely management to delay the onset of Alzheimer's disease (AD) would benefit patients. Pathological metabolic changes of excitatory/inhibitory neurotransmitters and abnormal protein deposition in the hipp...
Autores principales: | Chen, Xin, Gong, Tao, Chen, Tong, Xu, Changyuan, Li, Yuchao, Song, Qingxu, Lin, Liangjie, Oeltzschner, Georg, Edden, Richard A. E., Xia, Zhangyong, Wang, Guangbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995585/ https://www.ncbi.nlm.nih.gov/pubmed/36908797 http://dx.doi.org/10.3389/fnins.2023.1089300 |
Ejemplares similares
-
Protein-based amide proton transfer-weighted MR imaging of amnestic mild cognitive impairment
por: Zhang, Zewen, et al.
Publicado: (2019) -
Region-specific elevations of glutamate + glutamine correlate with the sensory symptoms of autism spectrum disorders
por: He, Jason L., et al.
Publicado: (2021) -
Amide Proton Transfer-Weighted MRI Might Help Distinguish Amnestic Mild Cognitive Impairment From a Normal Elderly Population
por: Guo, Zixuan, et al.
Publicado: (2021) -
Regional balance between glutamate+glutamine and GABA+ in the resting human brain
por: Steel, Adam, et al.
Publicado: (2020) -
Altered Volume and Structural Connectivity of the Hippocampus in Alzheimer’s Disease and Amnestic Mild Cognitive Impairment
por: Feng, Feng, et al.
Publicado: (2021)